featured
SGLT2 Inhibitors vs Placebo as Add-On Therapy in Type 2 Diabetes Uncontrolled With Metformin and a DPP-4 Inhibitor
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetic Medicine: A Journal of the British Diabetic Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of a Sodium-Glucose Co-Transporter-2 Inhibitor vs Placebo as an Add-On Therapy for People With Type 2 Diabetes Inadequately Treated With Metformin and a Dipeptidyl Peptidase-4 Inhibitor: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Diabet. Med. 2020 Sep 26;[EPub Ahead of Print], C De Buitléir, E O' Connor, MM Satti, J Shaw, A LiewFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.